Grace Therapeutics GRCE
NASDAQ GRCE
$1.97 -0.01 (-0.51%)
At close: Oct 21, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Capital Expenditures (2019 - 2024)

Updated

Grace Therapeutics (GRCE) reported Capital Expenditures of $22,000 for fiscal Q4 2024 (quarter ended Mar 31, 2024), up 175.0% from $8,000 a year earlier.

Analysis

Grace Therapeutics (GRCE) Capital Expenditures (2019 - 2024) Analysis & Trends

Dating back to fiscal Q1 2020, Grace Therapeutics' Capital Expenditures record includes 10 quarters.

  • Capital Expenditures has a five-year compound annual growth rate of -47.2% (FY2019 to FY2024).
  • By fiscal year, Capital Expenditures came in at $17,000 in FY2023, $69,000 in FY2021 (-78.4%) and $319,000 in FY2020 (-40.3%).
  • The fiscal Q4 2024 figure ranks as the highest quarterly Capital Expenditures since fiscal Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Grace Therapeutics 34.02 Mn -32.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 22,000.00
Mar 31, 2023 8,000.00
Sep 30, 2022 2,000.00
Jun 30, 2022 7,000.00
Sep 30, 2020 33,000.00
Jun 30, 2020 36,000.00
Mar 31, 2020 319,000.00
Dec 31, 2019 254,000.00
Sep 30, 2019 17,000.00
Jun 30, 2019 19,000.00
API Access

Grace Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GRCE&period=max&api_key=YOUR_API_KEY